| Dr Paul David D'ambrosio, MD | |
|
2284 Main St, Concord, MA 01742-3829 | |
| (978) 369-5575 | |
| (978) 371-9189 |
| Full Name | Dr Paul David D'ambrosio |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 40 Years |
| Location | 2284 Main St, Concord, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033194048 | NPI | - | NPPES |
| 3083004 | Medicaid | MA | |
| J11066 | Other | MA | BLUE CROSS |
| 071362 | Other | MA | TUFTS HEALTH PLAN |
| 60305 | Other | MA | HARVARD PILGRIM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 73162 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emerson Hospital Home Care Program | Concord, MA | Home health agency |
| Caretenders | Needham heights, MA | Home health agency |
| Bayada Home Health Care, Inc | Worcester, MA | Home health agency |
| Ascend Hospice | Marlboro, MA | Hospice |
| Care Dimensions, Inc | Danvers, MA | Hospice |
| Emerson Hospital - | W concord, MA | Hospital |
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
| Life Care Center Of Acton | Acton, MA | Nursing home |
| Entity Name | Concord Internal Medicine Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255485058 PECOS PAC ID: 2264615616 Enrollment ID: O20110323000531 |
News Archive
Federal Judge Richard Leon says the regulation ordering cigarette makers to put graphic images on the packages may "unconstitutionally compel speech."
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has resolved all disputes with Teva Pharmaceuticals USA, Inc. stemming from litigation brought by Mylan in federal court in the District of Columbia against the U.S. Food and Drug Administration (FDA) concerning Mylan's abbreviated new drug application (ANDA) for Modafinil Tablets, 100 mg and 200 mg.
We all have that Facebook friend - or 10 - who regularly posts photos of his or her fitness pursuits: on the elliptical at the gym, hiking through the wilderness, crossing a 10K finish line.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
A new study from researchers at the University of Ottawa Heart Institute (UOHI), published today in Cell Reports, sheds light on a mysterious gene that likely influences cardiovascular health.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul David D'ambrosio, MD 2284 Main St, Concord, MA 01742-3829 Ph: (978) 369-5575 | Dr Paul David D'ambrosio, MD 2284 Main St, Concord, MA 01742-3829 Ph: (978) 369-5575 |
News Archive
Federal Judge Richard Leon says the regulation ordering cigarette makers to put graphic images on the packages may "unconstitutionally compel speech."
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has resolved all disputes with Teva Pharmaceuticals USA, Inc. stemming from litigation brought by Mylan in federal court in the District of Columbia against the U.S. Food and Drug Administration (FDA) concerning Mylan's abbreviated new drug application (ANDA) for Modafinil Tablets, 100 mg and 200 mg.
We all have that Facebook friend - or 10 - who regularly posts photos of his or her fitness pursuits: on the elliptical at the gym, hiking through the wilderness, crossing a 10K finish line.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.
A new study from researchers at the University of Ottawa Heart Institute (UOHI), published today in Cell Reports, sheds light on a mysterious gene that likely influences cardiovascular health.
› Verified 8 days ago
Dr. William Judson Burtis, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 747 Main St, Suite 123, Concord, MA 01742 Phone: 978-287-9590 Fax: 978-287-5700 | |
C Gregory Martin, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 133 Ornac, Concord, MA 01742 Phone: 978-287-3111 Fax: 978-287-3675 | |
Richard P Schwartz, MD PC Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac Ste 510, John Cuming Building, Concord, MA 01742 Phone: 978-776-6186 Fax: 978-776-6189 | |
Thomas Lamattina, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Concord, MA 01742 Phone: 978-371-0796 | |
Dr. Peter Scott Benjamin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 Ornac, Concord, MA 01742 Phone: 978-287-3627 | |
Stephen M Dyda, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Concord, MA 01742 Phone: 978-287-8767 |